Merck and Eisai announced termination of a phase III trial of pembrolizumab plus lenvatinib (Lenvima) and transarterial chemoembolization (TACE) for unresectable liver cancer after an interim analysis ...
Deborah Young got a lung cancer scan on a whim, not expecting the call that followed to tell her she had a spot on her lung. “It was only like 1.8 ...
The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...
A Star Market grocery store in Newton, Massachusetts has been ordered to close due to the potential presence of asbestos.
Dr. Watson’s address distilled critical lessons into three actionable takeaways for individuals navigating the healthcare ...
CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, ...
The 2025 SCHEQ Lung Cancer Interventions Summit in Chicago was focused on one main goal: removing barriers and improving outcomes for everyone affected by lung cancer. By bringing patients, clinicians ...
A CANCER that creeps up quietly, spotted when it’s too late – 60 per cent of patients will die within a year of their ...
MAIA also announced that it has enrolled five patients from Taiwan and Turkey in the expansion phase of its THIO-101 Phase 2 trial. Screening for the trial is ongoing in Europe and Asia. With ...
A biopsy was ordered on May 2, 2024. In a text — her usual mode of communication, which she often used to make me laugh with ...
Outstanding measure of efficacy relative to high-risk cancers with limited treatment optionsCHICAGO, (GLOBE NEWSWIRE) -- MAIA ...
As explained by the National Breast Cancer Foundation, Inc., cancer is a group of diseases characterized by the growth and invasion of healthy cells by abnormal cells. Breast cancer specifically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback